CX3CR1+ macrophages support IL-22 production by innate lymphoid cells during infection with Citrobacter rodentium

Manta, C; Heupel, E; Radulovic, K; Rossini, V; Garbi, N; Riedel, C U; Niess, J H

doi:10.1038/mi.2012.61

Download PDF

Article
Open access
Published: 01 August 2012

CX₃CR1⁺ macrophages support IL-22 production by innate lymphoid cells during infection with Citrobacter rodentium

C Manta¹,
E Heupel²,
K Radulovic¹,
V Rossini¹,
N Garbi³,
C U Riedel² &
…
J H Niess¹

Mucosal Immunology volume 6, pages 177–188 (2013)Cite this article

5603 Accesses
95 Citations
3 Altmetric
Metrics details

Subjects

Abstract

Innate immune cells, such as intestinal epithelial cells, dendritic cells (DCs), macrophages, granulocytes, and innate lymphoid cells provide a first line of defence to enteric pathogens. To study the role of CX₃CR1⁺ DCs and macrophages in host defence, we infected CX₃CR1-GFP animals with Citrobacter rodentium. When transgenic CX₃CR1-GFP animals are infected with the natural mouse pathogen C. rodentium, CX₃CR1^−/− animals showed a delayed clearance of C. rodentium as compared with (age- and sex-matched) wild-type B6 animals. The delayed clearance of C. rodentium is associated with reduced interleukin (IL)-22 expression. In C. rodentium-infected CX₃CR1-GFP animals, IL-22 producing lymphoid-tissue inducer cells (LTi cells) were selectively reduced in the absence of CX₃CR1. The reduced IL-22 expression correlates with decreased expression of the antimicrobial peptides RegIIIβ and RegIIIγ. The depletion of CX₃CR1⁺ cells by diphtheria toxin injection in CX₃CR1-GFP × CD11c.DOG animals confirmed the role of CX₃CR1⁺ phagocytes in establishing IL-22 production, supporting the clearance of a C. rodentium infection.

Th1 responses in vivo require cell-specific provision of OX40L dictated by environmental cues

Article Open access 09 July 2020

Interferon regulatory factor 1 (IRF-1) promotes intestinal group 3 innate lymphoid responses during Citrobacter rodentium infection

Article Open access 29 September 2022

Tissue-based IL-10 signalling in helminth infection limits IFNγ expression and promotes the intestinal Th2 response

Article Open access 15 April 2022

Introduction

Innate immune cells, such as intestinal epithelial cells, dendritic cells (DCs), macrophages, granulocytes, and innate lymphoid cells (ILC) provide a first line of defence to insults in the gut, which is exposed to a complex intestinal microflora and, occasionally, pathogens.¹ Defective immune responses to the commensal microflora may mediate intestinal diseases such as Crohn's disease and ulcerative colitis.² Infiltration of DCs and macrophages is a characteristic of intestinal inflammation.³ The majority of F4/80^(high) CX₃CR1⁺ macrophages produce interleukin (IL)-10 in a CX₃CR1-dependent manner in the steady state,⁴ whereas a small population of F4/80^(low) CX₃CR1⁺ DCs secrete IL-12, IL-23, and tumor necrosis factor (TNF)-α, and are able to activate T cells.^{5, 6, 7} CX₃CR1 has been implicated in host defence to Salmonella and bacterial peritonitis,^{8, 9} but its role in host defence in the large intestine has not been studied in detail.

Citrobacter rodentium is a natural extracellular enteric mouse pathogen that serves as a mouse model of human infections with enteropathogenic Escherichia coli.¹⁰ C. rodentium colonizes the cecum and colon of mice after infection.¹¹ C. rodentium targets and infects intestinal epithelial cells by characteristic attaching and effacing lesions.¹² It represents an excellent model system to study innate host immune responses in the gut.¹³ Clearance of C. rodentium by the hosts partially depends on IL-22, a member of the extended IL-10 cytokine family, as shown in studies with IL-22^−/− animals.¹⁴ IL-22 induces expression of intestinal antimicrobial peptides (RegIIIβ and RegIIIγ, β-defensin-2, and β-defensin-3)¹⁵ and facilitates host responses by modulating the expression of various chemokines, including CXCL1, CXCL5, and CXCL9.^{16, 17, 18} IL-23 promotes IL-22 expression, as IL-23^−/− animals succumb to C. rodentium infection.^{19, 20} IL-1β, the γc cytokines IL-2, IL-7, and IL-15, and lymphotoxin controls the production of IL-22 by related orphan receptor gamma-t (RORγt)⁺ ILCs.²¹ Several ILCs have been recently described that are characterized by signature cytokines.²² IL-22 production is a characteristic of ILC22 cells. These cells share characteristics of lymphoid tissue inducer (LTi) and natural killer (NK) cells. ILC17 and LTi cells both produce IL-17A and IL-22.²² All ILC share an Id2-dependent precursor cell for their development.²² ILC22, ILC17, and LTi all express the transcription factor RORγt.

DCs and macrophages have been suggested to support the production of IL-22 by ILCs.²³ DCs support IL-22 production by ILCs in a lymphotoxin-dependent pathway.²⁴ In addition, DC-derived IL-23 and macrophage-derived IL-1β facilitates IL-22 production by ILCs.¹⁹ Addition of IL-25 to cultures of IL-17BR⁺ CD11c⁺ DCs/macrophages is able to suppress IL-22 production by RORγt⁺ ILCs.²⁵ In addition, Toll-like receptor agonists were shown to induce IL-22 expression by ILCs in vitro via stimulation of DCs and macrophages.²¹ However, the subset of DC or macrophages promoting ILC IL-22 expression is not yet identified.

Given the high abundance of CX₃CR1⁺ cells in the colonic lamina propria (cLP), we hypothesized that CX₃CR1⁺ phagocytes may have a role in regulating IL-22 production by ILCs in response to intestinal bacterial pathogens, and thus be critical for protection. Using a murine model of innate-mediated protection against C. rodentium, we show that clearance of C. rodentium is delayed in the absence of CX₃CR1. CX₃CR1-GFP animals on a recombination-activating gene (RAG)^−/− background are highly susceptible to C. rodentium infection. Absence of CX₃CR1 resulted in reduced IL-22 expression and reduced numbers of CD3⁻CD4⁺RORγt⁺CD127⁺CD117⁺ ILC cells. In addition, depletion of CX₃CR1⁺CD11c⁺ cells further indicated a role of CX₃CR1⁺CD11c⁺ macrophages in facilitating IL-22 production, supporting host defence against C. rodentium infection.

Results

Delayed C. rodentium clearance in absence of CX₃CR1 in CX₃CR1^GFP/GFP animals

The fractalkine receptor CX₃CR1 is required for the clearance of Salmonella in the small intestine^{8, 26} and in a peritoneal sepsis model,⁹ although the cellular and molecular mechanisms are not yet fully understood. Increased susceptibility of CX₃CR1^GFP/GFP animals, in which the green fluorescent protein (GFP) is inserted into two alleles of the CX₃CR1 locus and are hence CX₃CR1-deficient, to Salmonella can be in part explained by the reduced production of TNF-α, interferon-γ, IL-6, and inducible nitric oxide synthase.⁹ The infection of B6 and CX₃CR1^GFP/+, and CX₃CR1^GFP/GFP animals with C. rodentium is associated with an increased colonic fractalkine (CX₃CL1, the ligand of CX₃CR1) expression at day 12 and 20 post infection (p.i.; Supplementary Figure S1 online). To determine the contribution of CX₃CR1 to host defence to C. rodentium, we infected wild-type (wt, littermate controls) heterozygous CX₃CR1^GFP/+ and homozygous CX₃CR1^GFP/GFP animals²⁷ by oral gavage, and monitored the number of pathogenic bacteria in the feces for 27 days. In wt B6 animals C. rodentium burden in feces peaked between day 10–15, declined over time, and was not detectable at day 21, consistent with previous work from our group (Figure 1a).¹¹ Although the initial kinetics were comparable to control mice, C. rodentium burden in feces of CX₃CR1^GFP/+ and CX₃CR1^GFP/GFP animals remained >2 logs higher than in age- and sex-matched B6 animals on days 20 and 22 p.i., and complete C. rodentium clearance was delayed until day 27 p.i. for about 1 week (Figure 1a). The delayed clearance of C. rodentium in CX₃CR1^GFP/+ and CX₃CR1^GFP/GFP animals is associated with increased histopathological and macroscopic signs of C. rodentium-induced colitis (Figure 1b and c), increased colon weight/length ratios (Figure 1d), and reduced anti-C. rodentium immunoglobulin G (IgG) titers (Supplementary Figure S2 online). C. rodentium could not be detected in homogenates of mesenteric lymph nodes (MLNs), liver, and spleen of B6 animals, confirming previous reports (Figure 1e). By contrast, on day 12 p.i., C. rodentium could be cultured from homogenates of MLNs, liver, and spleen of CX₃CR1^GFP/+ and CX₃CR1^GFP/GFP animals (Figure 1e). C. rodentium counts were higher in CX₃CR1^GFP/GFP animals compared with CX₃CR1^GFP/+ animals in all organs tested, but this effect was not statistically significant. Thus, C. rodentium translocates across the intestinal epithelium to MLN and liver if CX₃CR1 levels are reduced or absent. Overall, these data indicated that CX₃CR1 is involved in the clearance of the C. rodentium infection, and deficiency in CX₃CR1 is associated with a significant increase in the severity of the C. rodentium infection.

C. rodentium localizes within CX₃CR1⁺ phagocytes

The C. rodentium infection is associated with an infiltration of CX₃CR1⁺ cells (Supplementary Figure S3 online). Significant differences between heterozygous and homozygous CX₃CR1-GFP animals were not observed (Supplementary Figure S3E and F online). Multi-color flow cytometry demonstrated that F4/80⁺CD11c⁺ macrophages and F4/80^(low)CD11c⁺ DCs expressed CX₃CR1 (Supplementary Figure S3B and C online). In C. rodentium-infected animals, an increase of the CX₃CR1⁺F4/80⁺CD11c⁺ macrophages was observed (Supplementary Figure S3B online). To examine C. rodentium infections in CX₃CR1^GFP/+ and CX₃CR1^GFP/GFP by fluorescence microscopy, we generated a red fluorescent C. rodentium strain (RF-C. rodentium) constitutively expressing the protein mRuby from a single copy of a derivative of plasmid p16Slux²⁸ integrated into the bacterial chromosome (Supplementary Figure S4 online). Intestinal tissues of infected animals were analyzed by ex vivo confocal imaging 12 days p.i. (peak infection). RF-C. rodentium had translocated into the cLP of the colon at peak infection (Figure 2a). RF-C. rodentium is closely associated with CX₃CR1⁺ cells and can be located within CX₃CR1⁺ cells (Figure 2a). RF-C. rodentium seems thus to be phagocytosed by CX₃CR1⁺ macrophages in the cLP. Flow cytometry confirmed the presence of RF-C. rodentium within CX₃CR1⁺ cells (Figure 2b). To further analyze the percentage of RF-C. rodentium located within CX₃CR1⁺ DCs and macrophages in heterozygous and homozygous CX₃CR1-GFP animals, CX₃CR1⁺ cells were defined as a region, for which colocalization of red and green fluorescent signals were analyzed by generating scatter diagrams (Figure 2c and d). In CX₃CR1^GFP/+ and CX₃CR1^GFP/GFP animals, C. rodentium is found within the CX₃CR1⁺ macrophages/DC at peak infection. CX₃CR1 seems to somewhat increase the uptake of C. rodentium (4.8 vs. 1.6%). Hence, C. rodentium is phagocytosed by CX₃CR1⁺ cells at peak infection.

Absence of CX₃CR1 is associated with reduced IL-22 expression

As IL-22 has an important role for the clearance of the C. rodentium infection,²⁹ we screened B6 and heterozygous and homozygous CX₃CR1-GFP animals for IL-22 expression. IL-22 mRNA expression was first determined by quantitative real-time PCR. IL-22 mRNA expression levels peaked at early infection (day 8 p.i.) and declined in the further course of the infection. Previous reports have already indicated that highest IL-22 expression can be found at early infection.^{29, 30} Infected CX₃CR1^GFP/GFP animals produced significant less IL-22 mRNA as compared with littermate controls (Figure 3a). IL-22 expression was >4-fold increased in C. rodentium-infected B6 mice at peak infection compared with noninfected controls. Significant differences between noninfected B6 and (age- and sex-matched) heterozygous and homozygous CX₃CR1-GFP animals were not observed (Figure 3b). In contrast, C. rodentium-infected CX₃CR1^GFP/GFP produced less IL-22 as compared with B6 animals (Figure 3b and e). At peak infection, differences in IL-10 production were not observed between heterozygous and homozygous CX₃CR1-GFP animals (data not shown), but IL-1β, IL12p40, and not IL-12p19 transcripts were reduced in these animals as compared with the B6 control mice (Supplementary Figure S5 online). Our results show that normal CX₃CR1 expression is required for optimal colonic IL-22 production in infected animals (Figure 3). Several cell population in the colon produce IL-22, including Th17, γδ T cells, ILC17, ILC22, and LTi cells as major producers.²² We carried out multi-color flow cytometry to investigate whether there was a specific cell population whose IL-22 production was particularly affected in mice with reduced CX₃CR1 expression. For this, cLP cell isolates from noninfected and C. rodentium-infected B6, heterozygous, and homozygous CX₃CR1-GFP animals were stained for IL-22, CD3ɛ, and CD4 (Figure 3c). In B6 mice, the population of CD4⁺CD3⁻IL-22⁺ cells increased from about ∼6% to over 20% upon infection with C. rodentium (Figure 3c,f). This population was significantly reduced in infected CX₃CR1^GFP/GFP mice compared with B6 animals (Figure 3e,f). The CD4⁻CD3⁻IL-22⁺ cells could be CD4⁻NKp46⁺RORγt and CD4⁻NKp46⁻RORγt ILCs.²⁵ Further analysis of the CD4⁺CD3⁻IL-22⁺ population revealed that these cells are characterized by RORγt, CD25, CD127, and CD117 expression, indicating that CD4⁺CD3⁻ IL-22-producing ILCs are LTi cells (Figure 3d). The reduced IL-22 expression in C. rodentium-infected CX₃CR1^GFP/GFP animals is associated with reduced RegIIIγ and RegIIIβ expression in the colon of infected CX₃CR1^GFP/GFP mice (Figure 3g,h), two secreted lectins involved in defence to pathogens in the intestinal tract.³¹ Our data indicated that reduced CX₃CR1 levels result in impaired IL-22 expression, specifically by CD4⁺CD3⁻ LTi cells in the colon of C. rodentium-infected animals, to a similar extent in CX₃CR1 heterozygous and knock-out mice. IL-22 has been shown to be critical for clearance of C. rodentium.²⁹ Thus, the reduced expression of IL-22 by colonic LTi in infected mice with reduced CX₃CR1 described here is a likely explanation of impaired C. rodentium clearance in these mice (Figure 1).

Accelerated lethality in RAG^−/− mice lacking CX₃CR1

To investigate the specific defect of LTi cells without the contribution of T-lymphocyte-produced IL-22, we next analyzed C. rodentium infections in RAG^−/− and RAG^−/− × CX₃CR1^GFP/GFP animals. We measured the body weight and collected fecal samples to determine the viable counts of C. rodentium. The experiment was ended when >15% body weight loss occurred or when infected animals displayed serious signs of colitis such as rectal prolapses. Unlike wt B6 animals, RAG^−/− animals did not clear the infection, confirming previous reports, and had to be killed by day 25 of infection (Figure 4a,b).³² The absence of CX₃CR1 in RAG^−/− × CX₃CR1^GFP/GFP animals resulted in an accelerated body weight loss and lethality as compared with RAG^−/− animals (Figure 4a,b). Also, C. rodentium infection in RAG^−/− × CX₃CR1^GFP/GFP is associated with increased macroscopic signs of C. rodentium-induced colitis (Figure 4c) and increased colon weight/colon length ratios (Figure 4d). Moreover, C. rodentium infection in RAG^−/− × CX₃CR1^GFP/GFP resulted in a strong reduction of IL-22-producing cells in the cLP. Reduced IL-22 mRNA expression was most evident at early infection (day 4 p. i.; Figure 4e). In addition, IL-22-expressing cells were reduced in RAG^−/− × CX₃CR1^GFP/GFP animals (Figure 4f and g). The CX₃CR1-dependent IL-22 production by LTi cells promotes innate immunity to enteric pathogens in the large intestine.

Depletion of CX₃CR1⁺ CD11c⁺ cells result in severe pathology

As CX₃CR1 is expressed by macrophages/DCs and NK cells (Supplementary Figure S3A online), we crossed CX₃CR1-GFP animals with CD11c.DOG animals to further examine the role of CX₃CR1⁺ CD11c⁺ cells for the induction of IL-22 production by innate lymphocytes without the possible contribution of CX₃CR1⁺ NK cells. Efficient depletion of CD11c⁺ cells can be achieved by diphtheria toxin injection over prolonged times.³³ CX₃CR1⁺CD11c⁺ phagocytes can be depleted for more than 14 days as indicated by flow cytometry analysis of isolates obtained from spleen, MLN, and cLP (Figure 5a). Fluorescence microscopy confirmed the efficient depletion of CX₃CR1⁺CD11c⁺ in CX₃CR1-GFP × CD11c.DOG animals (Figure 5b). We infected CD11c.DOG, CD11c.DOG × CX₃Cr1^GFP/+, and CD11c.DOG × CX₃CR1^GFP/GFP animals with C. rodentium. In infected CD11c.DOG, CD11c.DOG × CX₃CR1^GFP/+, and CD11c.DOG × CX₃CR1^GFP/GFP animals, CD11c⁺ cells were depleted by diphtheria toxin injection. The depletion of CX₃CR1⁺ CD11c⁺ cells resulted in an accelerated body weight loss (Figure 5c), increased lethality (Figure 5d), and increased C. rodentium load in MLN, spleen, and liver (Figure 5h). Significant differences between depleted CD11c.DOG, CD11c.DOG × CX₃CR1^GFP/+, and CD11c.DOG × CX₃CR1^GFP/GFP animals were not observed (Figure 5c, d and h). Further analysis revealed that IL-22 expression is reduced after the depletion of CX₃CR1⁺CD11c⁺ phagocytes (Figure 5e). Multi-color flow cytometry demonstrated that the CD4⁺CD3⁻IL-22⁺ innate cell population is reduced after the depletion of CX₃CR1⁺CD11c⁺ phagocytes (Figure 5e–g). CX₃CR1⁺CD11c⁺ DCs and macrophages hence seem to facilitate IL-22 production by ILCs during a C. rodentium infection.

Discussion

In this study, we identified a role of CX₃CR1⁺ phagocytes in clearance of a C. rodentium infection. Immunophenotyping by flow cytometry of CX₃CR1⁺CD11c⁺ cells demonstrated that CX₃CR1 is expressed by F4/80^(high)CD11c⁺ and F4/80^(low)CD11c⁺ cells in the cLP. CX₃CR1⁺CD11c⁺ cells encounter C. rodentium and support IL-22 production of ILCs in the cLP. In part, fractalkine/CX₃CL1 facilitates IL-22 production of ILCs by regulating IL-1β and IL-23p19 expression in C. rodentium-infected animals. Uptake of C. rodentium by CX₃CR1⁺ cells may serve as a defence mechanism to enteric pathogen and initiate innate immune responses by supporting IL-22 production by ILCs (Supplementary Figure S6 online).

We have not carried out our experiments with C. rodentium mutants lacking the structural components of a type III secretion system.³⁴ Hence, we cannot rule out that C. rodentium actively supports its uptake by CX₃CR1⁺ cells. Experiments with fluorescent noninvasive commensal E. coli strain have demonstrated that luminal bacteria are directly phagocytosed by CX₃CR1⁺ macrophages residing beneath the epithelium in the cLP (data not shown). CX₃CR1⁺ macrophages and DCs may hence serve as first sentinels after infection of the host with enteric pathogens and initiate rapid innate immune responses. Reduced IL-1β but not IL-23p19 transcripts were observed in infected CX₃CR1^GFP/GFP animals in absence of CX₃CR1. We speculate that phagocytosed C. rodentium provide signals to CX₃CR1⁺ phagocytes that help to facilitate IL-22 expression by ILCs. Reduced anti-C. rodentium IgG titers in CX₃CR1^GFP/GFP animals indicated that CX₃CR1 (beside its effects on IL-22 expression) may also be involved in regulating adaptive immune responses required for the clearance of C. rodentium. Polymorphism of the CX₃CR1 gene has been described to be associated with ileal Crohn's disease.³⁵ Our work indicates that the CX₃CR1–IL-22 axis could regulate REG IIIγ and REG IIIβ expression. In addition, IL-22 has epithelial regenerative properties, increasing intestinal epithelial cell proliferation and wound healing, which also has a role in the protection of the host.^{36, 37} Malfunction of the CX₃CR1–IL-22 axis may thus contribute to the development of Crohn's disease.

The stimulation of isolated CX₃CR1⁺ small intestine LP and cLP macrophages have dose-dependent effects on secretion of cytokines by macrophages.³⁸ Low concentration of CX₃CL1 decreased the production of TNF-α by lipopolysaccharide-stimulated macrophages.³⁸ High CX₃CL1 concentrations facilitate the production of pro-inflammatory cytokines, such as IL-23 and TNFα, in a peroxisome proliferator-activated receptor-γ-dependent mechanism.³⁸ In light of these observations, reduced IL-10 production by CX₃CR1⁺ macrophages was observed in the steady state and tolerogenic conditions.⁴ Bacterial peritonitis and/or injection of Clostridium difficile toxin A is associated with exacerbated disease in CX₃CR1^−/− animals.^{9, 39} In part, the increased susceptibility of CX₃CR1^−/− mice is mediated by impaired regulation of the heme oxygenase-1, TNF-α, IL-6, and inducible nitric oxide synthase production.^{9, 39} In spite of those findings, CX₃CR1 may provide environmental signals to macrophages that regulate their adaptation to microenviromental clues in the intestine.

As CX₃CR1 is expressed by DCs/macrophages and NK cells,^{5, 27, 40, 41, 42} we crossed CX₃CR1-GFP animals with CD11c.DOG animals to further examine the role of CX₃CR1⁺CD11c⁺ cells for the induction of IL-22 production by innate lymphocytes without the possible contribution of CX₃CR1⁺ NK cells. The depletion of CD11c⁺ macrophages and DCs resulted in increased susceptibility of transgenic animals to the C. rodentium infection. The depletion of CD11c⁺CX₃CR1⁺ macrophages was associated with reduced IL-22 production and reduced numbers of CD3⁻CD4⁺ RORγt⁺ LTi cells. The CD11c⁺ cell depletion gives similar results in CD11c.DOG and CD11c.DOG × CX₃CR1^GFP/GFP animals (that lack CX₃CR1). The lack of CX₃CR1 did not result to an additive effect after depletion of CD11c⁺ cells in infected animals. Thus, we would suggest a model in which CX₃CR1⁺ macrophages in the gut supports IL-22 production by ILCs in infected animals required for the clearance of C. rodentium.

Methods

Mice. Littermate C57BL/6J (B6) mice, CX₃CR1-GFP (B6.129P-Cx₃cr1^{tm1Li tt}/J), CD11c.DOG,³³ RAG^−/− (Rag1^tm1Mom), and RAG^−/− × CX₃CR1-GFP⁵ were bred and kept under specific pathogen-free conditions in the animal facility of the Ulm University (Ulm, Germany). CX₃CR1-GFP animals were crossed with CD11c.DOG mice to obtain CX₃CR1-GFP × CD11c.DOG animals. Female and male mice were used at 6–12 weeks of age. All animal experiments were performed with groups of age- and sex-matched animals, and carried out according to the guidelines of the local Animal Use and Care Committee and the National Animal Welfare Law.

C. rodentium infection. The strain C. rodentium ICC169 used in this study is a spontaneous nalidixic-acid-resistant mutant of the wt C. rodentium ICC168, which shows the same infectivity as the wt. RF-C. rodentium was generated by integrating the plasmid p16S_PT5mRuby into a 16S locus of the bacterial chromosome by homologous recombination (Supplementary Figure S3 online). To construct p16S_mRuby, the vector p16Slux²⁸ was cut with PstI to excise the luxABCDE genes and the P_help promotor. The fragment encoding mRuby, including the upstream T5 promotor, was amplified from the plasmid pQE-32_mRuby⁴³ using KOD Hot Start DNA polymerase (Merck, Nottingham, UK) and primers PT5mRuby_PstI.fwd (5′-AACTGCAGAGGCCCTTTCGTCTTCACC-3′) and PT5mRuby.rev (5′-GCTCAGCTAATTAAGCTTGGCTGC-3′). The PCR product was cut with PstI and ligated to the p16S plasmid to yield p16S_mRuby. To generate RF-C. rodentium, the vector p16S_mRuby was transformed into C. rodentium ICC169 by electroporation, using standard protocols. Transformants were selected by plating cells on Luria–Bertani (LB) agar containing 300 μg ml⁻¹ erythromycin, and resistant clones were tested for presence of p16S_mRuby by mini-prep and restriction analysis. Positive clones were incubated aerobically in LB broth containing erythromycin at 30 °C overnight, diluted 1:1,000 into fresh medium containing erythromycin, and incubated ∼6 h at 30 °C. Thereafter, bacteria were incubated overnight at the nonpermissive temperature (42 °C). Dilutions were plated on LB agar containing erythromycin and incubated at 42 °C. Under these conditions, p16S_mRuby is unable to replicate due to the thermosensitive origin of replication, and thus is forced to integrate into a 16S locus of the bacterial chromosome by homologous recombination in the presence of selective concentrations of erythromycin. Erythromycin-resistant colonies were checked for red fluorescence, and the integration of p16S_PT5mRuby was confirmed by PCR. C. rodentium was prepared by culturing bacteria aerobically overnight in LB broth containing nalidixic acid (50 μg ml⁻¹) at 37 °C and centrifuged at 3,000 g for 10 min as previously reported.¹¹ RF-C. rodentium displayed identical infectivity as the parental wt strain C. rodentium ICC169, both in terms of bacteria recovered from the feces at all timepoints of infection and the clinical symptoms (data not shown). Pelleted bacteria were washed and resuspended in phosphate-buffered saline (PBS). Mice (6–12 weeks) were inoculated orally with 2 × 10⁹ colony-forming units of either C. rodentium ICC169 (wt) or RF-C. rodentium. The weight of infected mice and their clinical condition were monitored every second day. Tissue samples were frozen in liquid nitrogen, cryosections were used and fixed in acetone at 4 °C for 30 min, mounted on slides, and stained with hematoxylin and eosin. Histology of the large intestine was categorized as for the severity of epithelial injury (graded 0–3, from absent to mild including superficial epithelial injury, moderate including focal erosions, and severe including multifocal erosions), the extent of inflammatory cell infiltrate (graded 0–3, from absent to transmural), and goblet cell depletion (0–3) as previously published.⁴⁴ In addition, the colon length and weight were determined, and colon weight/length ratios were calculated.

C. rodentium load in liver, spleen, MLNs, and feces. The organs were isolated aseptically from animals post mortem, and the organ weight was measured. The organs were then homogenized in sterile PBS. Serial dilutions of the homogenates were spotted on LB plates containing nalidixic acid (9 μg ml⁻¹) and nystatin (0.25 units ml⁻¹), incubated at 37 °C in a humidified atmosphere for 18 h, -forming units were counted, and bacterial load was calculated as cfu g⁻¹ tissue. Similarly, fecal pellets were collected from each animal every 2–3 days over the course of the infection, weighted, and resuspended in 1 ml of PBS, plated in serial dilutions, and bacterial load was calculated as cfu g⁻¹ feces.

Detection of anti- C. rodentium serum titers. Individual sera from littermate controls, heterozygous, or homozygous CX₃CR1-GFP mice were assayed for antigen-specific total IgG by enzyme-linked immunosorbent assay. Maxisorp immuno plates (catalog number (cat. no.) 442404; NUNC, Roskilde, Denmark) were coated with Gentamycin (10 μg ml⁻¹)-treated bacteria (1 × 10¹⁰ colony-forming units per well) and incubated overnight at 4 °C. After being blocked and washed, the plates were incubated with diluted serum samples from infected and negative control from noninfected animals. Horseradish peroxidase-conjugated goat anti-mouse Ig (cat. no. 554002; BD Biosciences, Heidelberg, Germany) was used to detect binding of serum antibodies to C. rodentium epitopes. The reaction was developed and read at 492 nm on a Bio-TEK Synergy HT microplate-ELISA reader (Bio-TEK, Winooski, VT) using KC4 (v3.1) software (Bio-TEK, Bad Friedrichshall, Germany).

Confocal microscopy. The colon from noninfected and C. rodentium-infected CX₃CR1-GFP mice were opened by longitudinal incision and rinsed with PBS as previously described.⁵ Living tissues were imaged with a LSM 710 confocal microscope (Zeiss, Jena, Germany). Colocalization analysis was carried out with the Zeiss ZEM software (Zeiss) by defining an area of interest and generating scatter diagrams. Image analysis was carried out with the LSM image browser (Zeiss) and Adobe Photoshop CS3.

Isolation of CX₃CR1⁺ cells or of ILCs from the cLP. Segments of the colon were washed with PBS to remove debris and mucous. The epithelium was removed by incubation at 37 °C for 30 min under gentle shaking with 1 mM dithiothreitol and 1 mM EDTA in Ca²⁺/Mg²⁺-free PBS supplemented with 1% fetal calf serum. The remaining tissue was washed in PBS to remove residual epithelial cells, and the supernatants were discarded. Denuded tissues were cut into two to three 2-mm pieces and digested with 0.5 mg ml⁻¹ collagenase type VIII (cat. no. C-2139; Sigma-Aldrich, St Louis, MO) and 5 U ml⁻¹ DNase (cat. no. 1284932; Roche, Basel, Switzerland) for 2 h at 37 °C in RPMI 1640/5% fetal calf serum. Supernatants were collected from which LP lymphocytes were pelleted. LP lymphocytes were resuspended in RPMI 1640 medium containing 40% Percoll (density 1.124 g dl⁻¹; cat. no. L-6145; Biochrome, Berlin, Germany). This cell suspension was overlaid onto 70% Percoll and centrifuged for 20 min at 750 g. Viable cells at the 40%/70% interface were collected and washed twice.

Flow cytometry analyses. Cells were washed twice in PBS/0.3% w/v bovine serum albumin supplemented with 0.1%w/v sodium azide. Nonspecific binding of antibodies to Fc receptors was blocked by pre-incubation of cells with monoclonal antibody (mAb) 2.4G2 (cat. no. 01241D; BD Biosciences) directed against the FcγRIII/II CD16/CD32 (1 μg/ml mAb per 10⁶ cells). Cells were washed and incubated with 0.5 mg per 10⁶ cells of the relevant mAb for 20 min at 4 °C and washed again twice. In most experiments, cells were subsequently incubated with a second-step reagent for 20 min at 4 °C. Four-color flow cytometry (FCM) analyses were performed using a FACSCalibur (BD Biosciences). The forward narrow-angle light scatter was used as an additional parameter to facilitate the exclusion of dead cells and aggregated cell clumps. Data were analyzed using FCS Express V3 software (De Novo Software, Los Angeles, CA).

Monoclonal antibodies. The following reagents and mAbs from eBioscience (Frankfurt, Germany) were used: antigen-presenting cell-conjugated mAb binding CD11c N418 (cat. no. 17-0114-82), anti-CD3 145-2C11 (cat. no. 553060), anti-CD25 PL61.5 (cat. no. 13-0251-81), and phycoerythrin-conjugated mAb-binding CD117 (c-Kit) 2B8 (cat. no. 12-1171-81). From BD Biosciences, the following biotinylated mAbs were used: anti–CD103 M290 (cat. no. 557493) and anti-CD3 145-2C11 (cat. no. 553060).

Intracellular cytokine staining. Cells (1 × 10⁶ per ml) from MLN or cLP were stimulated for 4 h at 37 °C with 50 ng ml⁻¹ PMA (cat. no. 79346; Sigma-Aldrich, St Louis, MO) and 500 ng ml⁻¹ Ionomycin (cat. no. 10634; Sigma-Aldrich) in the presence of 10 μg ml⁻¹ Brefeldin A (cat. no. ALX-350-019-M025; Alexis Biochemicals, Lörrach, Germany). Cells were harvested, washed, and stained with anti-CD3 145-2C11 (cat. no. 553060); eBioscience). Surface-stained cells were fixed (4% paraformaldehyde in PBS) and resuspended in permeabilization buffer (PBS, 0.5% bovine serum albumin, 0.5% saponin, 0.05% sodium azide). Permeabilized cells were incubated for 30 min at room temperature, dark with 0.25 μg/ml per 10⁶ cells of the following antibodies: phycoerythrin-conjugated anti-IL-10 JES5-16E3 (cat. no. 12-7101-81; eBioscience), anti-RORγt AFKJS-9 (cat. no. 12-6988-82; eBioscience), anti-IL-22 (cat. no. IC582P; R&D, Wiesbaden, Germany), and anti-IL-12/IL-23p40 C17.8 (cat. no. 12-7123-81); antigen-presenting cell-conjugated anti-IL22 (cat. no. IL582A; R&D). Stained cells were washed twice in permeabilization buffer and resuspended in PBS supplemented with 0.3% w/v bovine serum albumin and 0.1% w/v sodium azide. The number of cytokine-expressing innate cells was determined by FCM.

Cytokine detection by quantitative real-time PCR. RNA was prepared from frozen colon tissue using the RNAeasy mini kit (cat. no. 74904; Qiagen, Hilden, Germany). Contaminating genomic DNA was eliminated from samples by treatment with RNAse-free DNAse I (cat. no. 1010395; Qiagen). A total of 2 μg of RNA isolated from tissue or 200 ng of RNA isolated from tissues was reverse transcribed with SuperScript II Reverse Transcriptase (cat. no. 18064-014; Invitrogen, Paisley, Scotland) using random primers (cat. no. 48190-011; Invitrogen) according to the manufacturer's instructions. SYBR Green qPCR Master mix (cat. no. PA-012-12; SABiosciences, Valencia, CA) was used for amplification and detection. Real-time PCR reactions were performed using the 7500 Fast Real-Time PCR System (Applied Biosystems, Darmstadt, Germany) and the following conditions: 50 °C for 2 min, repeat 1; 95 °C for 10 min, repeat 1; 95 °C for 15 s, 60 °C for 1 min, repeats 40; 95 °C for 15 s, 60 °C for 1 min, 95 °C for 15 s, 60 °C for 15 s, repeat 1. β-actin PCR signals were used to equalize cDNA amounts between preparations. Following primers were used: β-actin (cat. no. PPM02945A; SABiosciences); REG IIIγ (cat. no. QT00147455; Qiagen); REG IIIβ (cat. no. QT00239302; Qiagen); Cx₃cl1 (cat. no. PPM0959E; SABiosciences); IL-1β ((forward) 5′-CTC AAT GGA CAG AAT ATC AAC CAA CA)-3′; IL-22 (cat. no. PPM05481A; Qiagen), IL-12p40 ((forward) 5′-ACT TGA AGT TCA ACA TCA AGA GCA GTA G-3′); IL-12p19 (IL23a) (cat. no. QT01663613; Qiagen). Expected product length: 154 bp for β-actin, 93 bp for REG IIIγ, 141 bp for REG IIIβ, 113 bp for Cx₃cl1, 28 bp for IL-12p40, 80 bp IL-12p19, 99 bp for IL-22, and 26 bp for IL-1β. β-actin PCR signals were used to equalize cDNA amounts between preparations.

Statistics. A one-way ANOVA test (for nonparametric) data and a t-test for two unequal variances were used. P<0.05 was considered statistically significant.

References

Strober, W. The multifaceted influence of the mucosal microflora on mucosal dendritic cell responses. Immunity 31, 377–388 (2009).
Article Google Scholar
Khor, B., Gardet, A. & Xavier, R.J. Genetics and pathogenesis of inflammatory bowel disease. Nature 474, 307–317 (2011).
Article Google Scholar
Maloy, K.J. & Powrie, F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 474, 298–306 (2011).
Article Google Scholar
Hadis, U. et al. Intestinal tolerance requires gut homing and expansion of FoxP3+ regulatory T cells in the lamina propria. Immunity 34, 237–246 (2011).
Article Google Scholar
Niess, J.H. & Adler, G. Enteric flora expands gut lamina propria CX3CR1+ dendritic cells supporting inflammatory immune responses under normal and inflammatory conditions. J. Immunol. 184, 2026–2037 (2010).
Article Google Scholar
Rivollier, A., He, J., Kole, A., Valatas, V. & Kelsall, B.L. Inflammation switches the differentiation program of Ly6Chi monocytes from antiinflammatory macrophages to inflammatory dendritic cells in the colon. J. Exp. Med. 209, 139–155 (2012).
Article Google Scholar
Kayama, H. et al. Intestinal CX3C chemokine receptor 1high (CX3CR1high) myeloid cells prevent T-cell-dependent colitis. Proc. Natl Acad. Sci. USA 109, 5010–5015 (2012).
Article Google Scholar
Niess, J.H. et al. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 307, 254–258 (2005).
Article Google Scholar
Ishida, Y. et al. Essential involvement of CX3CR1-mediated signals in the bactericidal host defense during septic peritonitis. J. Immunol. 181, 4208–4218 (2008).
Article Google Scholar
Mundy, R., MacDonald, T.T., Dougan, G., Frankel, G. & Wiles, S. Citrobacter rodentium of mice and man. Cell Microbiol. 7, 1697–1706 (2005).
Article Google Scholar
Symonds, E.L. et al. Involvement of T helper type 17 and regulatory T cell activity in Citrobacter rodentium invasion and inflammatory damage. Clin. Exp. Immunol. 157, 148–154 (2009).
Article Google Scholar
Borenshtein, D., McBee, M.E. & Schauer, D.B. Utility of the Citrobacter rodentium infection model in laboratory mice. Curr. Opin. Gastroenterol. 24, 32–37 (2008).
Article Google Scholar
Eckmann, L. Animal models of inflammatory bowel disease: lessons from enteric infections. Ann. NY Acad. Sci. 1072, 28–38 (2006).
Article Google Scholar
Aujla, S.J. et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat. Med. 14, 275–281 (2008).
Article Google Scholar
Wolk, K. et al. IL-22 increases the innate immunity of tissues. Immunity 21, 241–254 (2004).
Article Google Scholar
Harper, E.G. et al. Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis. J. Invest Dermatol. 129, 2175–2183 (2009).
Article Google Scholar
Liang, S.C. et al. IL-22 induces an acute-phase response. J. Immunol. 185, 5531–5538 (2010).
Article Google Scholar
Guilloteau, K. et al. Skin inflammation induced by the synergistic action of IL-17A, IL-22, Oncostatin M, IL-1{alpha}, and TNF-{alpha} recapitulates some features of psoriasis. J. Immunol. 184, 5263–5270 (2010).
Article Google Scholar
Sonnenberg, G.F., Monticelli, L.A., Elloso, M.M., Fouser, L.A. & Artis, D. CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut. Immunity 34, 122–134 (2011).
Article Google Scholar
Mangan, P.R. et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441, 231–234 (2006).
Article Google Scholar
Cella, M. et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457, 722–725 (2009).
Article Google Scholar
Spits, H. & Di Santo, J.P. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat. Immunol. 12, 21–27 (2011).
Article Google Scholar
Spits, H. Another armament in gut immunity: lymphotoxin-mediated crosstalk between innate lymphoid and dendritic cells. Cell Host Microbe 10, 3–4 (2011).
Article Google Scholar
Tumanov, A.V. et al. Lymphotoxin controls the IL-22 protection pathway in gut innate lymphoid cells during mucosal pathogen challenge. Cell Host Microbe 10, 44–53 (2011).
Article Google Scholar
Sawa, S. et al. RORgammat+ innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota. Nat. Immunol. 12, 320–326 (2011).
Article Google Scholar
Arques, J.L. et al. Salmonella induces flagellin- and MyD88-dependent migration of bacteria-capturing dendritic cells into the gut lumen. Gastroenterology 137, 579–587 (2009).
Article Google Scholar
Jung, S. et al. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol. Cell Biol. 20, 4106–4114 (2000).
Article Google Scholar
Riedel, C.U. et al. Construction of p16Slux, a novel vector for improved bioluminescent labeling of gram-negative bacteria. Appl. Environ. Microbiol. 73, 7092–7095 (2007).
Article Google Scholar
Zheng, Y. et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 14, 282–289 (2008).
Google Scholar
Ota, N. et al. IL-22 bridges the lymphotoxin pathway with the maintenance of colonic lymphoid structures during infection with Citrobacter rodentium. Nat. Immunol. 12, 941–948 (2011).
Article Google Scholar
Wehkamp, J., Schauber, J. & Stange, E.F. Defensins and cathelicidins in gastrointestinal infections. Curr. Opin. Gastroenterol. 23, 32–38 (2007).
Article Google Scholar
Simmons, C.P. et al. Central role for B lymphocytes and CD4+ T cells in immunity to infection by the attaching and effacing pathogen Citrobacter rodentium. Infect. Immun. 71, 5077–5086 (2003).
Article Google Scholar
Hochweller, K., Striegler, J., Hammerling, G.J. & Garbi, N. A novel CD11c.DTR transgenic mouse for depletion of dendritic cells reveals their requirement for homeostatic proliferation of natural killer cells. Eur. J. Immunol. 38, 2776–2783 (2008).
Article Google Scholar
Dahan, S. et al. EspJ is a prophage-carried type III effector protein of attaching and effacing pathogens that modulates infection dynamics. Infect. Immun. 73, 679–686 (2005).
Article Google Scholar
Brand, S. et al. Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease Phenotype. Am. J. Gastroenterol. 101, 99–106 (2006).
Article Google Scholar
Sugimoto, K. et al. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J. Clin. Invest. 118, 534–544 (2008).
Google Scholar
Brand, S. et al. IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am. J. Physiol. Gastrointest. Liver Physiol. 290, G827–G838 (2006).
Article Google Scholar
Mizutani, N. et al. Dose-dependent differential regulation of cytokine secretion from macrophages by fractalkine. J. Immunol. 179, 7478–7487 (2007).
Article Google Scholar
Inui, M. et al. Protective roles of CX3CR1-mediated signals in toxin A-induced enteritis through the induction of heme oxygenase-1 expression. J. Immunol. 186, 423–431 (2011).
Article Google Scholar
Fogg, D.K. et al. A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science 311, 83–87 (2006).
Article Google Scholar
Geissmann, F., Jung, S. & Littman, D.R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19, 71–82 (2003).
Article Google Scholar
Brand, S., Sakaguchi, T., Gu, X., Colgan, S.P. & Reinecker, H.C. Fractalkine-mediated signals regulate cell-survival and immune-modulatory responses in intestinal epithelial cells. Gastroenterology 122, 166–177 (2002).
Article Google Scholar
Kredel, S. et al. mRuby, a bright monomeric red fluorescent protein for labeling of subcellular structures. PLoS One 4, e4391 (2009).
Article Google Scholar
Conlin, V.S. et al. Vasoactive intestinal peptide ameliorates intestinal barrier disruption associated with Citrobacter rodentium-induced colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 297, G735–G750 (2009).
Article Google Scholar

Download references

Acknowledgements

This work was supported by grants Ni575/6-2 and Ni575/7-1 from the Deutsche Forschungsgemeinschaft (D. F. G.), the “Zukunftspreis” from the German Association for the Study of Inflammatory Bowel Disease (DACED) to J. H. N., the International Graduate School of Molecular Medicine of Ulm University (GSC270) to V. R., and a stipend of the summer school “Host-Microbe Interactions in the Intestinal Tract” Kiel, Germany and a poster award of the German Gastroenterology Society (DGVS) to C. M. The continuous support of G. Adler and G. von Wichert is acknowledged. Julia Geitner and Nathalie Birth supported our work by excellent technical help. This work is part of the thesis of C. M.

Author information

Authors and Affiliations

Department of Internal Medicine I, University of Ulm, Ulm, Germany
C Manta, K Radulovic, V Rossini & J H Niess
Institute of Microbiology and Biotechnology, University of Ulm, Ulm, Germany
E Heupel & C U Riedel
Department of Molecular Immunology, Institutes of Molecular Medicine and Experimental Immunology IMMEI, Bonn, Germany
N Garbi

Authors

C Manta
View author publications
You can also search for this author in PubMed Google Scholar
E Heupel
View author publications
You can also search for this author in PubMed Google Scholar
K Radulovic
View author publications
You can also search for this author in PubMed Google Scholar
V Rossini
View author publications
You can also search for this author in PubMed Google Scholar
N Garbi
View author publications
You can also search for this author in PubMed Google Scholar
C U Riedel
View author publications
You can also search for this author in PubMed Google Scholar
J H Niess
View author publications
You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J H Niess.

Ethics declarations

Competing interests

The authors declared no conflict of interest.

Additional information

SUPPLEMENTARY MATERIAL is linked to the online version of the paper

Supplementary information

Supplementary Figure S1 (JPG 75 kb)

Supplementary Figure S2 (JPG 50 kb)

Supplementary Figure S3 (JPG 360 kb)

Supplementary Figure S4 (JPG 234 kb)

Supplementary Figure S5 (JPG 120 kb)

Supplementary Figure S6 (JPG 233 kb)

Supplementary Figures Legends (DOC 31 kb)

PowerPoint slides

PowerPoint slide for Fig. 1

PowerPoint slide for Fig. 2

PowerPoint slide for Fig. 3

PowerPoint slide for Fig. 4

PowerPoint slide for Fig. 5

Rights and permissions

This work is licensed under the Creative Commons Attribution-NonCommercial-No Derivative Works 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/

Reprints and permissions

About this article

Cite this article

Manta, C., Heupel, E., Radulovic, K. et al. CX₃CR1⁺ macrophages support IL-22 production by innate lymphoid cells during infection with Citrobacter rodentium. Mucosal Immunol 6, 177–188 (2013). https://doi.org/10.1038/mi.2012.61

Download citation

Received: 25 October 2011
Accepted: 16 May 2012
Published: 01 August 2012
Issue Date: January 2013
DOI: https://doi.org/10.1038/mi.2012.61

This article is cited by

Intragraft immune cells: accomplices or antagonists of recipient-derived macrophages in allograft fibrosis?
- Xiaoping Li
- Jing Wu
- Jingtao Chen
Cellular and Molecular Life Sciences (2023)
Inflammation triggers ILC3 patrolling of the intestinal barrier
- Angélique Jarade
- Zacarias Garcia
- Nicolas Serafini
Nature Immunology (2022)
Targeting cellular fatty acid synthesis limits T helper and innate lymphoid cell function during intestinal inflammation and infection
- Panagiota Mamareli
- Friederike Kruse
- Matthias Lochner
Mucosal Immunology (2021)
The AIM2 inflammasome is a central regulator of intestinal homeostasis through the IL-18/IL-22/STAT3 pathway
- Rojo A Ratsimandresy
- Mohanalaxmi Indramohan
- Christian Stehlik
Cellular & Molecular Immunology (2017)
Diversity and functions of intestinal mononuclear phagocytes
- T. Joeris
- K. Müller-Luda
- A McI Mowat
Mucosal Immunology (2017)